Evaluation of transnasal videoendoscopic-guided botulinum toxin injection in patients with adductor spasmodic dysphonia
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Introduction: Adductor spasmodic dysphonia (ASD) is a focal laryngeal dystonia characterized by involuntary vocal fold spasms, resulting in a strained and effortful voice. Botulinum toxin injection is the standard treatment, typically performed using electromyography-guided techniques. Aim: This study evaluates the efficacy of office-based transnasal videoendoscopic-guided botulinum toxin injection as an alternative to electromyography-guided percutaneous injection in patients with adductor spasmodic dysphonia (ASD). Methods: A cohort of patients with ASD underwent transnasal laryngeal injections of botulinum toxin using a flexible video endoscope. Local anesthesia was administered, and a flexible needle was used to inject botulinum toxin into the vocal and/or vestibular folds. Phonation was assessed before and after the procedure. Results: Twenty-seven patients with ASD showed significant improvements in VHI-10 (Voice Handicap Index-10) and VRQOL (Voice Related Quality of Life) scores post-injection. Additionally, the GRBAS scale scores improved after the procedure. Conclusions: Office-based transnasal videoendoscopic-guided botulinum toxin injection is a reliable and straightforward technique for treating ASD. It can be performed without electromyography, making it accessible for all laryngologists.
Fields of Study & Subjects
Voice and Speech Disorders
Botulinum Toxin and Related Neurological Disorders
Respiratory and Cough-Related Research
Publication details
- Journal / source
- Otolaryngologia Polska
- Volume
- 80
- Issue
- 3
- Pages
- 1–6
- Publication date
- 31 March 2026
- Language
- EN